The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what FDA Peptide Reclassification 2026 Amanecia Health Nine Anticipated FDA Approvals for January 2026 Guideline Central GHK Cu 99%+ Pure Peptide Amino Club Amino Club FDA Review Moves Peptides From Gray Market to Mainstream Fitt Insider Buy GHK Cu 50mg & 100mg Copper Tripeptide Koi Peptides